BioCentury
ARTICLE | Clinical News

Amlexanox: Phase IV data; marketed

December 4, 2000 8:00 AM UTC

In a Phase IV European trial, amlexanox paste prevented ulcer formation when applied at the first sign or symptom of the disease, as detected by thermographic evaluation of the mouth. The number of pa...